Locally Advanced or Metastatic Non-Small Cell Lung Cancer Clinical Trial
Official title:
A Phase II, Open Label, Multi-center Study to Assess the Efficacy and Safety of JMT101 Combined With Osimertinib in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations
This study is a phase II, open label, multi-center study to evaluate the efficacy and safety of JMT101 combined with Osimertinib in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring EGFR exon 20 insertion mutations.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05513664 -
Real-World Effectiveness of Osimertinib for Patients With Non-Small Cell Lung Cancer
|
||
| Recruiting |
NCT05048797 -
A Study to Investigate the Efficacy and Safety of Trastuzumab Deruxtecan as the First Treatment Option for Unresectable, Locally Advanced/Metastatic Non-Small Cell Lung Cancer With HER2 Mutations
|
Phase 3 | |
| Recruiting |
NCT04606446 -
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
|
Phase 1 | |
| Recruiting |
NCT05673590 -
Utidelone Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
|
Phase 3 | |
| Recruiting |
NCT04686305 -
Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
|
Phase 1 | |
| Recruiting |
NCT04448379 -
Efficacy and Safety of JMT101 Combined With Afatinib (or Osimertinib) in Patients With Non-Small Cell Lung Cancer
|
Phase 1 | |
| Recruiting |
NCT05863325 -
A Study to Compare the Efficacy and Safety of HB1801 to Taxotere in Advanced Non-Small Cell Lung Cancer (NSCLC)
|
Phase 2 | |
| Recruiting |
NCT04996121 -
A Study of XZP-5955 Tablets in Patients With NTRK or ROS1 Fusion Positive Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 |